Phase I: Solid tumors
FOCUS AREA
SOLID TUMORS
DEVELOPMENT STAGE
PHASE I
TARGET
7
12
Title
CD137 FAP bispecific agonist antibody + ezabenlimab
Order
16
Subtitle pipeline
Combination
SEO Description
CD137 FAP bispecific agonist antibody + ezabenlimab